Trial intelligence / Profile preview

Doripenem multiple-dose pharmacokinetics during renal and liver extracorporeal support

2009-018010-18Phase 4Completed

Sponsor
Medical University of Vienna
Start
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of doripenem (3 cohorts), sponsored by Medical University of Vienna. Primary endpoints: Area under the concentration-time curve, Half-life and 6 more. Started Apr 2010; status: completed.

02

Drugs

doripenem

Beyond the preview

Go deeper on 2009-018010-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-018010-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call